 | Your browser does not display parts of our website correctly. We use the latest technology available to provide you with a high quality experience; please upgrade your browser to its latest version to view the contents properly: |
Gentherm Incorporated (THRM) designs, develops, and manufactures thermal management technologies and cable systems worldwide.
It operates through three segments: Climate Controlled Seats (CCS), Advanced Technology, and W.E.T.
The CCS segment offers products with variable temperature seat climate control systems for individualized thermal comfort to automobile passengers. It also provides automotive heated and cooled cup holders, and heated and cooled mattress products. This segment sells its products primarily to automobile and light truck original equipment manufacturers (OEMs), or their tier one suppliers.
The Advanced Technology segment is engaged in the advanced research and development activities to improve the efficiency of thermoelectric devices, as well as to develop, market, and distribute products based on these new technologies. The W.E.T. segment manufactures automotive seat comfort systems, specialized automotive cable systems, and other non-automotive product solutions.
Its automotive seat comfort products include automotive seat heaters, climate comfort systems, and steering wheel heater systems, as well as integrated electronic components, such as blowers and electronic control units; and specialized automotive cable systems products consist of ready-made wire harnesses and related wiring products. This segment serves passenger car OEMs, commercial vehicle OEMs, and tier one seat manufacturers, as well as the telecommunication, information technology, and medical equipment industries.
Shares have formed a bullish "cup and handle" after the firm reported a better than expected quarterly report. Higher share prices are expected for this stock.
52-Week Trading Range: $16.52 - $41.44
Entry Point: $40.99
Stop Loss: $38.95
Target Price: $45.10
We are taking profits on THRM after it failed to reach our target price in 30 days or less. Closed at $43.10.
